Novo Nordisk | NVO - Pre Tax Profit



Novo Nordisk reported DKK37.03B in Pre-Tax Profit for its fiscal quarter ending in March of 2025.


Pre Tax Profit Change Date
ANI Pharmaceuticals USD 10.52M 9.47M Jun/2025
Aurora Cannabis CAD -19380000 51.45M Jun/2025
Bausch Health Companies USD 140M 187M Jun/2025
Bristol-Myers Squibb USD 1.77B 1.2B Jun/2025
Canopy Growth CAD -41240000 80.34M Jun/2025
Corcept Therapeutics USD 31.69M 22.07M Jun/2025
Drreddys Laboratories 19.05B 304M Jun/2025
Eli Lilly USD 6.78B 3.32B Jun/2025
GlaxoSmithKline GBP 1.89B 221M Jun/2025
Merck USD 6.77B 864M Jun/2025
Novartis USD 4.53B 124M Jun/2025
Novo Nordisk 33.8B 3.23B Jun/2025
Novo Nordisk DKK 37.03B 2.65B Mar/2025
Pacira USD -1927000 10.63M Jun/2025
Perrigo USD 3.2M 5.1M Jun/2025
Prestige Brands USD 61.78M 12.18M Jun/2025
Sanofi EUR 1.42B 734M Jun/2025
Supernus Pharmaceuticals USD 16.67M 22.5M Jun/2025
Zoetis USD 902M 92M Jun/2025